Aldeyra Therapeutics (ALDX)
(Real Time Quote from BATS)
$4.11 USD
-0.06 (-1.44%)
Updated May 8, 2024 10:02 AM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | -75.00% |
ABR | 1.00 |
Earnings ESP
|
-1.96% |
---|---|
Current Year | -0.17 |
Next Year | -0.43 |
EPS (TTM) | -0.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 100.00M | 35.61M |
# of Estimates | NA | NA | 1 | 3 |
High Estimate | NA | NA | 100.00M | 67.30M |
Low Estimate | NA | NA | 100.00M | 18.70M |
Year ago Sales | 0.00M | 0.00M | NA | 100.00M |
Year over Year Growth Est. | NA | NA | NA | -64.39% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.16 | -0.17 | -0.43 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.17 | -0.19 | -0.72 | -0.63 |
High Estimate | -0.10 | -0.15 | 1.15 | 0.55 |
Low Estimate | -0.17 | -0.19 | -0.72 | -0.85 |
Year ago EPS | -0.15 | -0.14 | -0.64 | -0.17 |
Year over Year Growth Est. | 13.33% | -14.29% | 73.44% | -152.94% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 3 | 1 |
Down Last 7 Days | 1 | 1 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.16 | -0.17 | -0.43 |
7 Days Ago | -0.12 | -0.15 | -0.14 | -0.43 |
30 Days Ago | -0.12 | -0.15 | -0.14 | -0.43 |
60 Days Ago | -0.11 | -0.15 | -0.31 | -0.44 |
90 Days Ago | NA | NA | -0.45 | -0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.15 | -0.60 | -0.43 |
Zacks Consensus Estimate | -0.13 | -0.16 | -0.17 | -0.43 |
Earnings ESP | -1.96% | 6.25% | -247.83% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.08 | -0.14 | -0.15 | NA |
Estimate | -0.08 | -0.21 | NA | -0.31 | NA |
Difference | -0.06 | 0.13 | NA | 0.16 | 0.08 |
Surprise | -75.00% | 61.90% | NA | 51.61% | 12.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more